Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy

Marzia De Bortoli1, Chiara Calore2, Alessandra Lorenzon1

  • 1Department of Biology, University of Padua, Padua, Italy.

Insights

Co-inheritance of arrhythmogenic cardiomyopathy (ACM) and hypertrophic cardiomyopathy (HCM) gene mutations was observed in two families. Double heterozygotes showed variable clinical expression, not a more severe phenotype than single mutation carriers.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Basis of Cardiomyopathies

Background:

  • Arrhythmogenic cardiomyopathy (ACM) and hypertrophic cardiomyopathy (HCM) are distinct genetic myocardial disorders.
  • Genetic mutations are known causes for ACM and HCM individually.
  • The implications of co-inheriting mutations for both conditions are not well understood.

Purpose of the Study:

  • To investigate the co-inheritance of ACM and HCM-associated gene mutations in families with recurrent cardiomyopathies.
  • To analyze the clinical presentation and phenotype of individuals with double heterozygous mutations.

Main Methods:

  • Genetic analysis of two families with recurrent ACM and HCM.
  • Identification of mutations in genes such as DSP, MYBPC3, CTTNA3, and MYH7.
  • Clinical phenotyping and assessment against diagnostic criteria for ACM and HCM.

Main Results:

  • Co-inheritance of DSP and MYBPC3 mutations in Family A, with affected individuals diagnosed with either ACM or HCM.
  • Identification of CTTNA3 and MYH7 mutations in Family B, with one patient not meeting criteria for either cardiomyopathy.
  • Variable clinical expression observed in double heterozygotes, without a consistently more severe phenotype compared to single mutation carriers.

Conclusions:

  • This study presents the first evidence of co-inheritance of ACM and HCM-associated mutations.
  • Double heterozygosity can lead to variable presentations, including diagnoses of ACM or HCM, or phenotypes not meeting current criteria.
  • The clinical impact of co-inheriting these specific mutations requires further investigation, as severity is not uniformly increased.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
651
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534